Premenstrual syndrome

Premenstrual syndrome (PMS) is a complex of mental and physical symptoms that is observed in women of reproductive age and manifests itself on certain days before the onset of menstruation. PMS symptoms cover a wide range, including emotional changes (irritability, depressive states), physical manifestations (chest pain, headache, swelling) and changes in behavior (problems with sleep, appetite). The variety of manifestations and their severity can vary significantly from one woman to another, which makes diagnosis and treatment of this pathology quite difficult. PMS is of great clinical importance, since it affects the quality of life of a woman, requiring a comprehensive approach to diagnosis and therapy.

History of the disease and interesting historical facts

Premenstrual syndrome was first described in medical literature in the early 20th century, but its study began much earlier. In 1931, American gynecologist S. E. Gruber identified symptoms associated with the menstrual cycle as a separate group. In 1953, the prescription of drugs to relieve PMS symptoms began to actively develop, and research in this area has continued since then. Different cultures have had different beliefs and understandings of menstruation, including the idea that women are burdened with some kind of “negative” influence during this period, which is also reflected in folklore and literature. Thus, PMS is not only a medical but also a socio-cultural problem, which makes its study especially important.

Epidemiology

According to statistics, about 50-80% women of reproductive age suffer from premenstrual syndrome. About 20-40% of them experience symptoms that are severe enough to require specialized care. According to international literature, in 3-8% cases, the symptoms are severe and develop into premenstrual dysphoric disorder (PMDD), which requires active drug intervention. Epidemiological data show a high incidence rate, which emphasizes the importance of further research and understanding of the pathogenesis of this syndrome.

Genetic predisposition to this disease

Research has shown that premenstrual syndrome may have a genetic predisposition. In particular, certain gene polymorphisms associated with susceptibility to PMS have been identified. Interestingly, mutations in genes regulating the serotonin, dopamine, and gamma-aminobutyric acid systems may be associated with the development of this condition. Many studies are attempting to identify specific genes, such as serotonin receptors and genes responsible for the biosynthesis of neurotransmitters, which may open up new perspectives in understanding the mechanisms of PMS.

Risk factors for the development of this disease

There are a number of risk factors that contribute to the development of premenstrual syndrome:

• Genetic predisposition - a family history of PMS or PD.
• Hormonal changes - fluctuations in estrogen and progesterone levels before menstruation.
• Stress - low stress tolerance can worsen symptoms.
• Lifestyle - lack of physical activity, poor nutrition and alcohol abuse.
• Mental disorders such as depression and anxiety disorders increase the risk of developing PMS.

These factors may interact with each other to increase the likelihood of PMS in women.

Diagnosis of this disease

Diagnosis of premenstrual syndrome is based on the assessment of the clinical picture and includes several basic methods:

• The main symptoms are emotional fluctuations, physical discomfort, changes in appetite and sleep.
• Laboratory tests - analysis of hormone levels, genitourinary tests to exclude other diseases.
• Radiological examinations - ultrasound of the pelvic organs to identify possible pathologies associated with the menstrual cycle.
• Other types of diagnostics include keeping a symptom diary to assess their cyclicality.
• Differential diagnosis involves excluding other mental disorders and somatic diseases such as hypothyroidism or polycystic ovary syndrome.

This comprehensive approach allows us to more accurately determine the presence of premenstrual syndrome and prescribe appropriate treatment.

Treatment

Treatment for premenstrual syndrome can be divided into several categories:

• General treatment involves lifestyle changes, including healthy eating, physical activity, and stress management.
• Pharmacological treatment - the use of antidepressants, anti-inflammatory drugs and hormonal drugs to correct symptoms.
• Surgical treatment may be recommended in extreme cases when other methods do not bring results, especially in the presence of concomitant gynecological diseases.
• Other treatments include psychotherapy, acupuncture, herbal medicine and other alternative methods.

The selection of treatment tactics is determined individually and takes into account the severity of symptoms and the general health of the patient.

List of medications used to treat this disease

Modern approaches to drug treatment of PMS include:

• Antidepressants (selective serotonin reuptake inhibitors).
• Nonsteroidal anti-inflammatory drugs, such as ibuprofen.
• Hormonal contraceptives for hormonal regulation.
• Preparations containing magnesium, calcium and B vitamins.

Each of these remedies may be used depending on individual symptoms and tolerance.

Disease monitoring

Monitoring of premenstrual syndrome includes:

• Control stages - regular examinations by a gynecologist and psychotherapist.
• Prognosis: With adequate therapy, most women experience improvement in their condition.
• Complications - If left untreated, symptoms can progress and lead to more serious mental disorders.

Effective therapy and monitoring can prevent the development of more severe forms of the disease.

Age-related features of the disease

Premenstrual syndrome can manifest itself differently depending on the age group:

• Adolescents - symptoms may be less pronounced, but there is a predisposition to them.
• Women aged 20-30 years - high probability of developing PMS, especially in the presence of stress and fatigue.
• Women over 35 years of age - symptoms may increase due to approaching menopause and hormonal changes.

Studying age-related characteristics allows us to adapt the approach to treatment and prevention of this syndrome.

Questions and Answers

• What is premenstrual syndrome?
  Premenstrual syndrome is a group of physical and mental symptoms that occur in women before menstruation.
• What are the most common symptoms of PMS?
  The most common symptoms are emotional fluctuations, swelling, headaches and changes in appetite.
• How can PMS be diagnosed?
  Diagnosis includes medical history, clinical examination and keeping a symptom diary.
• What treatments are used for PMS?
  Treatment may include lifestyle changes, drug therapy, and psychotherapy.
• Does premenstrual syndrome affect quality of life?
  Yes, PMS can significantly reduce the quality of life, causing emotional and physical suffering.

Thus, premenstrual syndrome remains a significant medical problem that requires further research to understand its mechanisms and optimize diagnostic and treatment methods.